* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
None
Delistings:
Just Group (JUST.L) has left the Equity Shares (Commercial Companies) segment of the Main Market.
What’s baking in the oven?
Potential IPOs:***
17 March: Vista Parcs Group has announced its intention to IPO onto AIM. The newly incorporated entity is proposing to acquire a portfolio of 13 UK-based holiday and residential parks currently owned by Barney Group 2 Ltd (BG2) and operated by Baslow Parks Ltd. Deal details TBC and expected Admission date anticipated late March 2026.
4 March: Scotch Corner Designer Village Holdings plc, which is developing a largely pre-let retail and leisure destination in the North of England, announced its intention to apply for Admission to trading on the Aquis Real Asset Market (ARAM) segment of the Aquis Stock Exchange Growth Market. The Company is seeking to raise £25.5m. The listing is expected to complete in April 2026.
Market Movers:***
1st April: Oscillate (AQSE: SRVL), the company focused on building an independent copper and future metals developer, announced that further to the announcement on 9 February 2026 of the conditional acquisition of Kalahari Copper, it has conditionally completed an equity fundraising of £2.9m and plans to move to AIM from AQSE. Net proceeds of the Fundraising will allow for the advancement of the Company's proposed exploration assets in Namibia and Botswana. In addition, the company will change its name to Serval Resources and Admission to AIM is expected to occur on or around 8.00 am on 27 April 2026.
Banquet Buffet****
Catenai 0.31p £3.66m (CTAI.L)
The provider of technology and digital solutions, notes that Alludium Ltd, its investee company and developer of a no-code AI Agent Operating System, has achieved ISO 27001:2022 certification and received its SOC 2 Type II attestation, enhancing its potential to sell to enterprise clients. The achievements give third party assurance of the Companies Information Security practices and its commitment to protecting customer data, since many enterprise sized organisations only transacting with supplier partners that can demonstrate this level of compliance. ISO 27001:2022 is the internationally recognised standard for information security management systems while SOC 2 is an attestation standard governed by the American Institute of Certified Public Accountants that evaluates whether an organisation's controls related to security operate effectively over a defined observation period.
Cizzle Biotechnology Holdings 2.10p £8.32m (CIZ.L)
The UK based diagnostics developer of early cancer tests, announces that it has entered into a new facility to provide the Company with up to £250k through the potential issue of further unsecured convertible loan notes to Frazer Lang, an existing investor in the Company. The Facility provides the Company with access to funds to be used if required to support its future commercial growth strategy. This is specifically the commercial launch of the Company's CIZ1B biomarker test in North America to help in early-stage lung cancer detection, to facilitate the roll out of the test in the UK and elsewhere in Europe, and to further its collaboration and clinical evaluations with the Moffitt Cancer Center in Florida, USA. The Company has now completed the draw down of funds totalling £400k to Frazer Lang, with £150k in Convertible Loan Notes issued in May 2025.
Eden Research 2.85p £17.79m (EDEN.L)
The developer and supplier of sustainable biopesticide and biocontrol technologies announced that the Company's partner, Véto-pharma, has received regulatory approval from the US Environmental Protection Agency for Thymolflex for use in integrated Varroa management. Thymoflex is a thymol-based treatment used in bee health to control Varroa destructor, an external parasitic mite that attacks and feeds on honey bees. This approval follows an announced agreement, signed by the Company in April 2025, to supply Véto-pharma with thymol for use in bee care products.
Halo Minerals 13.13p £14.5m (HALO.L)
The copper development Company focused on extracting critical minerals from legacy mining waste announced it has contracted specialised environmental consultancy firm MSTECK SpA and engaged a team led by Ms. María Carolina Parodi Dávila. The team will conduct a comprehensive bio-accessibility and human health risk assessment study at Halo's Playa Verde Project site in Chañaral, Chile. The Company has also engaged an energy & infrastructure consultant to review, optimise and delineate power requirements and access for the Project's mining and processing operations as set out in the Project's existing definitive feasibility study.
Panther Metals 77.50p £6.73m (PALM.L)*
The mineral explorer focused on assets in Canada today announced the appointment of Donna-Belen Humphreys to the Board of Directors of the Company as a non-executive director. Donna has over 25 years of experience across investor relations, corporate development, compliance, marketing, and strategic planning within public and private financial markets, including junior mining, real estate finance, mortgage, and insurance sectors. Donna replaces Tracy Hughes who has stepped down as a non-executive director. The appointment and resignation are effective from 1 April. Panther Metals further announces that 16,000 Ordinary Shares are to be admitted to trading relating to the allotment to Evoke Digital Solutions Limited in connection with services provided in relation to the Company's historic Bitcoin strategy. The Company currently holds no Bitcoin and has no further contractual obligations to Evoke Digital Solutions Limited.
Satsuma Technology 0.20p £21.96m (SATS.L)
The provider of AI-based conversational technologies is implementing a revised cost reduction strategy that involves reduction in staffing levels, renegotiation of advisory and service provider contracts, the rationalisation of consultancy arrangements, and the reduction of expenditure that is not aligned with the Company's current scale and strategy. The reductions are expected to reduce the Group's annualised operating expenditure from approximately £6.7m to approximately £2.7m, with further reductions expected. This represents an initial annualised saving of approximately £4.2m, or 62% to date, and provides a cash runway of over 24 months of operating costs, without requiring any additional revenue or capital raising. The company also reported it has so far purchased 25.65 Bitcoin at an average price of £51,939 per coin.
Speedy Hire 19.18p £101.61m (SDY.L)
The tools and equipment hire services Company operating across the construction, infrastructure and industrial markets provided a trading update for the year to 31 March 2026. The Group made progress in FY2026 with a
commercial agreement with Proservice Building Services Marketplace Plc, with the integration continuing as planned and the agreement remaining on track to generate £50-55m of revenue and be earnings accretive in its first full year of trading. At the interim results on 26 November 2025, the Company anticipated a continuation of subdued market conditions for the remainder of FY2026. Market conditions have worsened through Q4, with uncertainty around the UK Budget in November and the recent geopolitical events in the Middle East. The Company has also seen certain customer led delays affecting hire and service revenues, which are now expected to impact positively in the near term. As a result, the Board now expects FY2026 EBITDA to be c.£90m.
Tanfield Group 7.15p £11.16m (TAN.L)
The passive investing Company reports results for FY December 2025. The Company currently continues to value the 49% interest in Snorkel International at £19.1m. In October 2019, the Board received US Proceedings, in which Xtreme, via its subsidiary SKL and Snorkel International, alleged that Tanfield refused to sign over its interest in Snorkel International for £nil consideration which is disputed. The Board believes it is reasonable to expect that the investment in Snorkel International will result in a return of value to shareholders in the future. The loss for the FY to December from operations was £1.8m which is up from £0.4m; the difference being an increase in legal costs associated with the US Snorkel Proceedings. At 31 December 2025, the Company had cash and short-term deposits of £2.1m, compared to £3.2m in the prior year and approximately £1.5m as at of the FY results announcement.
Tavistock Investments 3.35p £16.64m (TAVI.L)
The specialist wealth and asset management Company focused on meeting the specific needs of private investors completes the acquisition of Lifetime. This was originally announced in September 2025 and the FCA change in control approval has now been granted. Lifetime's digital-first platform makes appropriate and significant use of technology and AI, but only in support of qualified professionals and with guaranteed human involvement. Lifetime will continue its development of an advisory ecosystem to deliver a targeted tenfold increase in adviser productivity as its hybrid model breaks down traditional barriers to financial advice and wealth creation.
Tracsis 310.00 £91.54m (TRCS.L)
The transport technology provider reports the acquisition of Vesputi GmbH, a German digital ticketing technology company. The gross initial consideration of £5.1m includes net cash c.£0.7m cash and is funded from Tracsis' existing cash resources, with additional consideration of up to £2.1m on performance. This bolt-on acquisition is immediately earnings enhancing and expands Tracsis' digital ticketing capability and establishes a small operational foothold in the German public transport market. Vesputi generates revenue primarily through transaction revenues linked to the volume of tickets processed and the six full-time staff will remain with the Company. The Acquisition is consistent with the Group's growth transformation strategy focused on growing recurring software licence and consumer-driven transactional revenues, while continuing to diversify internationally.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
